BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6295736)

  • 1. Cyproheptadine-induced remission of Cushing's disease due to pituitary basophil adenoma.
    Jimenez-Alonso J; Munoz-Avila J; Jaimez L; Pérez-Jimenez F; Bellido C; Jiménez-Perepérez JA
    Drug Intell Clin Pharm; 1982 Dec; 16(12):962-5. PubMed ID: 6295736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproheptadine treatment in Cushing's disease.
    Tanakol R; Alagöl F; Azizlerli H; Sandalci O; Terzioğlu T; Berker F
    J Endocrinol Invest; 1996 Apr; 19(4):242-7. PubMed ID: 8862505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.
    Ooi TC; Twum-Barima Y
    J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of ruptured dissecting aneurysm 5 years after pituitary microsurgical treatment of Cushing's disease: autopsy findings in the hypothalamic-pituitary-adrenal axis.
    Suzuki T; Sasano H; Murakami O; Nagura H
    Endocr J; 1993 Oct; 40(5):613-8. PubMed ID: 7951528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
    Tucci JR; Nowakowski KJ; Jackson IM
    J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's disease. Therapy of pituitary adenomas.
    Tyrrell JB; Wilson CB
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):925-38. PubMed ID: 7705327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's disease in a young woman with anorexia nervosa: pathophysiological implications.
    Katz JL; Weiner H; Kream J; Zumoff B
    Can J Psychiatry; 1986 Dec; 31(9):861-4. PubMed ID: 3026602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing's disease revisited.
    Wilson CB; Tyrrell JB; Fitzgerald P
    Am J Surg; 1979 Jul; 138(1):77-9. PubMed ID: 223465
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.
    Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E
    Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central nervous system and Cushing's disease.
    Krieger DT
    Med Clin North Am; 1978 Mar; 62(2):261-8. PubMed ID: 205739
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of pituitary dependent Cushing's disease with clinical and biochemical features of the ectopic ACTH syndrome.
    Hale AC; Millar JB; Ratter SJ; Pickard JD; Doniach I; Rees LH
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):479-88. PubMed ID: 2985302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathology of Cushing's syndrome].
    Saeger W; Mitschke H
    Dtsch Med Wochenschr; 1973 Jun; 98(25):1272-5. PubMed ID: 4351688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cushing's disease due to pituitary gland tumor and paradoxical response to dexamethasone].
    Peillon F; Boyet F; Malinsky M
    Nouv Presse Med; 1974 Dec; 3(45):2727-8. PubMed ID: 4376599
    [No Abstract]   [Full Text] [Related]  

  • 15. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
    Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant pituitary adenoma presenting as Cushing's syndrome.
    Garg SK; Ahmad Z; Kak VK; Dash RJ
    J Assoc Physicians India; 1987 Jul; 35(7):536-8. PubMed ID: 2828304
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclical Cushing's disease: two distinct rhythms in a patient with a basophil adenoma.
    Atkinson AB; Chestnutt A; Crothers E; Woods R; Weaver JA; Kennedy L; Sheridan B
    J Clin Endocrinol Metab; 1985 Feb; 60(2):328-32. PubMed ID: 2981244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's disease caused by ectopic pituitary adenoma within the pituitary stalk.
    Tal A
    South Med J; 1993 Feb; 86(2):249-50. PubMed ID: 8381988
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.
    Ishibashi M; Yamaji T
    J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's disease in a 5-month infant due to a basophilic microadenoma of the pituitary gland.
    Castro EC; Ferraz ML; Corrêa RR; Reis MA; Texeira VP
    J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1263-6. PubMed ID: 17172089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.